Shriram Bioseed, KeyGene collaboration

2018-06-07 12:58:53

In a separate agreement, Hyderabad-based Shriram Bioseed, a DCM Shriram Ltd group company and KeyGene have signed a multi-year strategic co-development research program. The program will be for the development of improved rice hybrids with higher yields, increased tolerance to abiotic stresses, and better grain quality for consumers in India and Southeast Asia.According to a press release issued b

Read more

ICRISAT, KeyGene ink LoI to co-work on novel crop technologies

2018-06-07 12:56:16

This is considered as a global partnership on technologies that could potentially benefit millions of smallholder farmers across Asia and Africa.By Team ABLEThe Netherlands-based agricultural biotech company KeyGene and not–for-profit scientific research organization, the International Crops Research Institute for Semi-Arid Tropics (ICRISAT) signed a Letter of Intent (LoI), for research and co-d

Read more

BASF, Evogene sign multiyear collaboration for novel insecticides development

2018-06-07 12:50:45

BASF and biotechnology company Evogene have entered into a new collaboration focusing on the development of novel insecticides. By Team ABLELeading chemical company BASF and biotechnology company Evogene have entered into a new collaboration focusing on the development of novel insecticides based on new binding areas (Site-of-Action or ‘SoA’) on key insecticidal target proteins. The parties al

Read more

Substantial economic costs reported due to Chinese delays on Ag-Biotech approvals: Informa report

2018-06-07 12:45:59

Persistent delays in China’s ag-biotech regulatory system slows U.S. farmers’ access to new biotechnology products and costs the U.S. economy tens of thousands of jobs and billions in economic output, according to a new study released today by Informa’s Agribusiness Consulting Group (Informa). By Team ABLEAccording to a news filed on the BIO website, persistent delays in China’s Ag-biotech

Read more

India Pavilion inaugurated @ BIO Boston

2018-06-07 09:59:36

\n\n\n \n \n \n \n\n\n\n

Boston, USA ,\nJune 5, 2018: India’s biotech industry was present in full\nstrength at the annual BIO Boston International Conference and\nConvention at the India Pavilion, set up by the Association of\nBiotechnology Led Enterprises (ABLE), on behalf of the Department of\nBiotechnology, Government of India.

\n

Read more

Meet India\'s Most Exciting Biotechs @ ABLE\'s INNONATION = INDIA™ meeting on June 5, 2018, 3:30p.m - 06:30p.m in Hyatt Regency, Boston, USA

2018-05-28 06:03:07

India is one of the emerging centers for start-ups in the Tech and Life Sciences space. Supported by forward looking policies of the central and state governments several hubs like Bangalore, Pune, Chennai, NCR etc. are gaining momentum. India’s ease of business ranking has improved rapidly in the past few years and is expected to improve further. The levels of the FDI have gone up substantially

Read more

Why biotech innovator Novozymes uses the SDGs as a catalyst for growth

2018-05-16 11:01:39

By Heather Clancy, Editorial Director, GreenBizNovozymes\n president and CEO Peder Holk Nielsen is optimistic that the world has \nthe willingness and the technology to tackle climate change.

But \nhe worries that too many well-intentioned companies are wasting time \ntaking action because they’re looking for perfect solutions for the long\n term rather than embracing good ones that have the p

Read more

Preliminary research shows noninvasive therapy may reverse atherosclerosis

2018-05-16 09:57:22

Researchers at Northwestern University Feinberg School of Medicine have developed a treatment for atherosclerosis that’s made of tiny peptide nanofibers. By Team ABLEAn injection may one day be able to reverse atherosclerosis, according to emerging research presented at the American Heart Association\'s Vascular Discovery: From Genes to Medicine Scientific Sessions 2018, a premier global exchang

Read more

Breast cancer: Discovery of a protein linked to metastasis

2018-05-16 09:50:25

Scientists at Montreal Clinical Research Institute have discovered that a protein called AXL influences metastasis of HER2-positive breast cancer, which accounts for about 20% of breast cancers. In experiments in human tumor cells and mice, they demonstrated that high levels of AXL increase the likelihood of cancer cells detaching from tumors and spreading. By Team ABLEJean-François Côté, a res

Read more

2018-05-16 09:46:30

Breast cancer: Discovery of a protein linked to metastasisScientists at Montreal Clinical Research Institute have discovered that a protein called AXL influences metastasis of HER2-positive breast cancer, which accounts for about 20% of breast cancers. In experiments in human tumor cells and mice, they demonstrated that high levels of AXL increase the likelihood of cancer cells detaching from tumo

Read more